QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, September 20, 2006, 26(38):9794-9804; doi:10.1523/JNEUROSCI.2116-06.2006

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Kaneko, S. Articles by He, Z. Search for Related Content PubMed PubMed Citation Articles by Kaneko, S. Articles by He, Z. Pubmed/NCBI databases Gene Compound via MeSH Substance via MeSH

 Previous Article  |  Next Article 

Cellular/Molecular
Protecting Axonal Degeneration by Increasing Nicotinamide Adenine Dinucleotide Levels in Experimental Autoimmune Encephalomyelitis Models

Shinjiro Kaneko,¹ Jing Wang,¹ Marie Kaneko,¹ Glenn Yiu,¹ Joanna M. Hurrell,¹ Tanuja Chitnis,² Samia J. Khoury,² and Zhigang He¹

¹Division of Neuroscience, Children's Hospital Boston, Harvard Medical School, and ²Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115

Correspondence should be addressed to Zhigang He, Division of Neuroscience, Children's Hospital Boston, Enders #379, 320 Longwood Avenue, Boston, MA 02115. Email: zhigang.he{at}childrens.harvard.edu

Axonal damage is a major morphological alteration in the CNS of patients with multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). However, the underlying mechanism for the axonal damage associated with MS/EAE and its contribution to the clinical symptoms remain unclear. The expression of a fusion protein, named "Wallerian degeneration slow" (Wld^s), can protect axons from degeneration, likely through a -nicotinamide adenine dinucleotide (NAD)-dependent mechanism. In this study, we find that, when induced with EAE, Wld^s mice showed a modest attenuation of behavioral deficits and axon loss, suggesting that EAE-associated axon damage may occur by a mechanism similar to Wallerian degeneration. Furthermore, nicotinamide (NAm), an NAD biosynthesis precursor, profoundly prevents the degeneration of demyelinated axons and improves the behavioral deficits in EAE models. Finally, we demonstrate that delayed NAm treatment is also beneficial to EAE models, pointing to the therapeutic potential of NAm as a protective agent for EAE and perhaps MS patients.

Key words: axon degeneration; EAE; NAD; Wallerian degeneration; nicotinamide; Wld^s

---

Received May 18, 2006; revised Aug. 3, 2006; accepted Aug. 10, 2006.

Correspondence should be addressed to Zhigang He, Division of Neuroscience, Children's Hospital Boston, Enders #379, 320 Longwood Avenue, Boston, MA 02115. Email: zhigang.he{at}childrens.harvard.edu

This article has been cited by other articles:

				T. Chitnis, J. Imitola, Y. Wang, W. Elyaman, P. Chawla, M. Sharuk, K. Raddassi, R. T. Bronson, and S. J. Khoury Elevated Neuronal Expression of CD200 Protects Wlds Mice from Inflammation-Mediated Neurodegeneration Am. J. Pathol., May 1, 2007; 170(5): 1695 - 1712. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help